Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Livagen and Ovagen Interaction: Synergistic | Peptide Database

Compound Profiles Livagen KEDA Tetrapeptide | Liver Bioregulator Livagen works through direct effects on DNA structure and function. It decondenses chromatin (tightly packed DNA), increasing expression of certain genes and improving the 'youthful' profile of c

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Livagen

KEDA Tetrapeptide | Liver Bioregulator

Livagen works through direct effects on DNA structure and function. It decondenses chromatin (tightly packed DNA), increasing expression of certain genes and improving the 'youthful' profile of cells.

Ovagen

EDL Tripeptide | Liver & GI Bioregulator

Ovagen works through epigenetic regulation by crossing cell and nuclear membranes to directly regulate DNA structure and transcription patterns. It is transported into cells via POT family transporters (PEPT1, PEPT2) that specifically handle di- and tripeptides, explaining its precise tissue targeting.

Shared Safety Flags

Frequently Asked Questions

Can I take Livagen with Ovagen?

Yes, Livagen and Ovagen can generally be taken together. Complementary liver bioregulators with different sequences.

Is Livagen and Ovagen safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Livagen and Ovagen?

Complementary liver bioregulators with different sequences. This assessment has 95% confidence and is based on documented research data.

How should I time Livagen and Ovagen?

Livagen has a half-life of Not established and Ovagen has a half-life of Not established. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Clinical efficacy shown in osteochondrosis, osteoarthritis, and osteoporosis treatment. Supports cartilage maintenance and joint function. Supports bone and connective tissue healing. Increased Ki-67 expression with suppressed apoptosis in young and aged cells. Enhances collagen synthesis in connective tissue. Inhibited MMP-9 synthesis; maintained extracellular matrix integrity.

Source: peptide-db.com ↗

Why is VIP rarely used clinically if research shows such promise?

VIP's extremely short 1-2 minute half-life makes it impractical for routine clinical use - requiring constant infusions or multiple daily injections. Stabilized analogs (like stearyl-Nle17-VIP) are 100-fold more potent but rarely available outside research settings. Limited commercial development has restricted clinical availability despite strong research foundation.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

YK-11 is administered exclusively via the oral route. It is available as a liquid solution (typically in PEG-400 or similar carrier) or in capsule form from research chemical suppliers. Due to its 17-alpha alkylated steroidal structure, it has sufficient oral bioavailability to be effective when taken by mouth. The estimated half-life of 6-10 hours (based on structural analogy rather than pharmacokinetic studies) necessitates twice-daily dosing to maintain more stable plasma concentrations throughout the day. Research Dose - Conservative 5 mg/day (2.5 mg AM + 2.5 mg PM) Twice daily (split AM/PM) Oral (liquid or capsule) Research Dose - Moderate 10 mg/day (5 mg AM + 5 mg PM) Research Dose - Upper Range 15 mg/day (7.5 mg AM + 7.5 mg PM)

Source: peptide-db.com ↗
Potential benefits

What's the benefit of nandrolone over testosterone for joints?

Nandrolone has superior collagen synthesis effects -- it directly stimulates type I and III collagen production in tendons and ligaments, improving synovial fluid production and joint lubrication. Testosterone alone doesn't produce this benefit to the same degree. At 50-100 mg/week with testosterone, nandrolone provides meaningful joint relief that many athletes notice within 4-6 weeks.

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides